Christopher Chen, MD
Radiation Oncology · Coral Springs, FLNPI 1245235688
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Novocure Inc. accounts for 61.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $5,147 and has fallen 89.9% since, to $521 in 2025.
Across 124 payments — averaging $69.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$5K
- Johnson & Johnson$597
- Myriad Genetic Laboratories, Inc.$572
- Dendreon Pharmaceuticals LLC$369
- Novartis$256
- Regeneron Healthcare Solutions, Inc.$170
- plus $1K from 23 others
Across 9 payments — averaging $2752.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$20K
- Janssen Research & Development, LLC$5K
What the payments were for
- Speaking & faculty fees$4,00046%
- Travel & lodging$6568%
- Food & beverage$3,93746%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 23 | $5,327 |
| Johnson & Johnson | 9 | $597 |
| Myriad Genetic Laboratories, Inc. | 26 | $572 |
| Dendreon Pharmaceuticals LLC | 14 | $369 |
| Novartis | 12 | $256 |
| Regeneron Healthcare Solutions, Inc. | 3 | $170 |
| Medtronic | 4 | $166 |
| GT Medical Technologies, Inc | 1 | $159 |
| Boston Scientific | 4 | $148 |
| Advanced Accelerator Applications | 1 | $129 |
| Bayer | 4 | $83 |
| Monteris Medical Corporation | 1 | $66 |
| Myovant Sciences Inc. | 3 | $62 |
| Blue Earth Diagnostics | 2 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Siemens Medical Solutions USA, Inc. | 1 | $49 |
| Tactile Systems Technology Inc | 2 | $49 |
| Palette Life Sciences, Inc. | 1 | $41 |
| Reflexion Medical, Inc. | 1 | $39 |
| Teleflex LLC | 1 | $34 |
| AstraZeneca | 1 | $32 |
| Napo Pharmaceuticals Inc | 1 | $30 |
| Telix Pharmaceuticals | 1 | $27 |
| AbbVie | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $16 |
| Pfizer | 1 | $13 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,617 in reported general payments places this provider in the 85th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Coral Springs
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
- Alan BrownFort Myers$165K
- Akash NandaOrlando$165K
- Michael ChuongMiami$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.